Search
for
Sort by
Research 211–240 of 445
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- New and Emerging Therapies for Alopecia Areata
- Tufted hair folliculitis developing in a recalcitrant lesion of pemphigus vulgaris
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Alopecia Areata after Omalizumab Treatment for Chronic Spontaneous Urticaria
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model
- Synthetically programmed antioxidant delivery by a domesticated skin commensal
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Dietary Habits in Japanese Patients with Alopecia Areata
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Drug-induced hair pigmentation: Clinical perspectives and updates
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- 75392 Psychosocial Burden of Severe Pediatric Alopecia Areata and Strategies for Mitigation: A Narrative Evidence Synthesis
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- Netherton Syndrome: A Case-Based Review of Diagnosis, Management, and Emerging Treatments.
- 50285 Oxytocin receptor is present in keratinocytes near touch and pain sensory neurons
- 48853 The AI Doctor will see you now: Can ChatGPT-4 be used to safely counsel patients with allergic contact dermatitis?
- 50832 Confetti variant of Alopecia Areata: A Single Center Retrospective Study to Describe a Novel Entity
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Recent approaches of antibody therapeutics in androgenetic alopecia
- LB1012 The development of a pediatric alopecia areata treatment classification system based on results from a systematic review
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?